Protection against SARS-CoV-2 Beta variant in mRNA-1273 vaccine–boosted nonhuman primates

BETA (programming language) Coronavirus Booster dose 2019-20 coronavirus outbreak
DOI: 10.1126/science.abl8912 Publication Date: 2021-10-22T03:58:45Z
ABSTRACT
A look at variant-specific boosters The evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants concern (VOCs) has raised the question whether current COVID-19 vaccines protect against VOCs and if a variant specific vaccine may be needed. Of currently identified VOCs, Delta is believed to most transmissible, whereas Beta appears resistant. Corbett et al . looked effect boosting using either original WA-1 strain or variant–specific booster. Around 6 months after primary two-dose series, third boost vaccination resulted in higher neutralizing antibody levels nonhuman primates. Regardless was from Beta-specific version, similar increases were observed enhanced viral protection. —PNK
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (46)
CITATIONS (88)